Literature DB >> 16225555

Benefits and limitations of antidepressants and traditional mood stabilizers for treatment of bipolar depression.

Joseph F Goldberg1, S Nassir Ghaemi.   

Abstract

OBJECTIVE: The aim of this paper was to review the rationales, risks, and benefits for using standard antidepressants versus mood stabilizing agents and/or atypical antipsychotics to treat bipolar depression.
METHOD: A selective literature review was conducted using key terms and by reference known to the authors. Bibliographies of articles and book chapters were further scrutinized for relevant literature.
RESULTS: The strengths and limitations of current studies are described and critically reviewed in order to present optimal strategies for effective pharmacotherapy. Clinical factors that can mitigate or confound simple bivariate relationships between antidepressant use and outcome have seldom been examined using multivariate statistical techniques. For many of the key questions there is a paucity of informative literature and randomized clinical trials are of limited value in addressing some of the issues.
CONCLUSIONS: Clinicians and investigators should be aware of the methodological shortcomings of existing studies. Decisions about the relative merits versus contraindications for antidepressant use should be made via more individualized, case-by-case profiling rather than by rigid prescribing practices.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16225555     DOI: 10.1111/j.1399-5618.2005.00251.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  11 in total

1.  Mood-Stabilizing Effect of Twice-Weekly Administration of Fluoxetine in a Bipolar II Disorder Patient.

Authors:  Amir Shabani
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

2.  Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.

Authors:  Jay D Amsterdam; Justine Shults
Journal:  Am J Psychiatry       Date:  2010-04-01       Impact factor: 18.112

3.  Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.

Authors:  Jay D Amsterdam; Lorenzo Lorenzo-Luaces; Irene Soeller; Susan Qing Li; Jun J Mao; Robert J DeRubeis
Journal:  J Affect Disord       Date:  2015-06-26       Impact factor: 4.839

4.  Comorbid anxiety in children and adolescents with bipolar spectrum disorders: prevalence and clinical correlates.

Authors:  Regina Sala; David A Axelson; Josefina Castro-Fornieles; Tina R Goldstein; Wonho Ha; Fangzi Liao; Mary Kay Gill; Satish Iyengar; Michael A Strober; Benjamin I Goldstein; Shirley Yen; Heather Hower; Jeffrey Hunt; Neal D Ryan; Daniel Dickstein; Martin B Keller; Boris Birmaher
Journal:  J Clin Psychiatry       Date:  2010-09-07       Impact factor: 4.384

5.  Predictors of bipolar disorder risk among patients currently treated for major depression.

Authors:  Joseph R Calabrese; David J Muzina; David E Kemp; Gary S Sachs; Mark A Frye; Thomas R Thompson; David Klingman; Michael L Reed; Robert M A Hirschfeld
Journal:  MedGenMed       Date:  2006-08-15

6.  Comparison of treatment outcome using two definitions of rapid cycling in subjects with bipolar II disorder.

Authors:  Jay D Amsterdam; Lorenzo Lorenzo-Luaces; Robert J DeRubeis
Journal:  Bipolar Disord       Date:  2017-02-03       Impact factor: 6.744

Review 7.  Antidepressants and psychostimulants in pediatric populations: is there an association with mania?

Authors:  Michelle Goldsmith; Manpreet Singh; Kiki Chang
Journal:  Paediatr Drugs       Date:  2011-08-01       Impact factor: 3.022

8.  Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder.

Authors:  Jay D Amsterdam; Lola Luo; Justine Shults
Journal:  Br J Psychiatry       Date:  2012-10-25       Impact factor: 9.319

9.  Rapid versus non-rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk.

Authors:  L Lorenzo-Luaces; J D Amsterdam; I Soeller; R J DeRubeis
Journal:  Acta Psychiatr Scand       Date:  2016-01-24       Impact factor: 6.392

Review 10.  Long-term remission and recovery in bipolar disorder: a review.

Authors:  Joseph F Goldberg; Jessica L Garno; Martin Harrow
Journal:  Curr Psychiatry Rep       Date:  2005-12       Impact factor: 8.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.